Non-transfusion-dependent Thalassemia
📧 Sign up to get email alerts when something new happens for Non-transfusion-dependent Thalassemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia [Phase 2, Phase 3]
Phase 2/3 trial evaluating the effect of L-glutamine on pulmonary arterial pressure in patients with non-transfusion-dependent thalassemia. …
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia [Phase 2]
Phase 2 trial updates the safety, tolerability, PK/PD, and preliminary efficacy of VIT-2763 in beta-thalassemia with non-transfusion-depende…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet [Phase 2]
Phase 2 open-label multicenter trial assessing patient preference for deferasirox film-coated tablet versus dispersible tablet in thalassemi…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia [Phase 4]
Phase 4 trial update on deferasirox for patients with non-transfusion dependent thalassemia assessing efficacy and safety; results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: The Effective and Safety of Thalidomide in NTDT [Phase 2]
Trial update on the effectiveness and safety of thalidomide in non-transfusion-dependent thalassemia (Phase 2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study [Phase 2]
Phase 2 trial update shows efficacy and safety of deferasirox in patients with iron overload and non-transfusion-dependent thalassemia, incl…